Drugs / FluLavalTM-VB
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01196975 Comparator | Oct 2010 → Jan 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluLavalTM-VB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01196975 ↗ |
| Modality | Vaccine | “one dose of FluLaval®-VB vaccine containing the Victoria B flu strain.” NCT01196975 ↗ |
| Route | Intramuscular | “The FluLaval®-VB vaccine was administered intramuscularly in the deltoid region of the non-dominant arm.” NCT01196975 ↗ |